SNY
Sanofi
NASDAQ · Healthcare · Drug Manufacturers - General · FR
$44.24
−0.20%Institutional positioning
13F filings over the trailing two quarters
New 195Increased 506Reduced 526Sold out 103
| Filer | Action | Shares | Filed |
|---|---|---|---|
| DODGE & COX | Reduced | 29,504,632 | May 14, 2026 |
| DODGE & COX | Reduced | 28,088,274 | Aug 13, 2026 |
| MORGAN STANLEY | Reduced | 12,511,867 | May 15, 2026 |
| FISHER ASSET MANAGEMENT, LLC | Reduced | 11,442,163 | May 5, 2026 |
| MORGAN STANLEY | Reduced | 10,702,527 | Aug 13, 2026 |
| Fisher Asset Management, LLC | Reduced | 10,627,088 | Aug 4, 2026 |
| BANK OF AMERICA CORP /DE/ | Increased | 9,484,350 | May 18, 2026 |
| BANK OF AMERICA CORP /DE/ | Reduced | 8,008,572 | Aug 14, 2026 |
| FRANKLIN RESOURCES INC | Increased | 7,165,193 | May 13, 2026 |
| Invesco Ltd. | Increased | 6,798,961 | Aug 14, 2026 |
| INVESCO LTD. | Increased | 6,621,539 | May 12, 2026 |
| JPMORGAN CHASE & CO | Increased | 6,573,682 | Aug 12, 2026 |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC | Reduced | 5,887,466 | May 13, 2026 |
| JPMORGAN CHASE & CO | Increased | 5,600,731 | May 13, 2026 |
| Mondrian Investment Partners LTD | Increased | 5,522,564 | Jul 30, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings